The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography

Cardiology Journal

Volumn 20, Issue 3, 2013, Pages 261-267

  Ghaffari, Samad ^a,b   Yaghoubi, Alireza ^a,b   Baghernejad, Roya ^a   Sepehrvand, Nariman ^b   Sokhanvar, Sepideh ^b   Haghjou, Amir Ghorbani ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Coronary artery disease; Osteoprotegerin

Indexed keywords

OSTEOPROTEGERIN;

ACUTE CORONARY SYNDROME; ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ATHEROSCLEROSIS SCORE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THORAX PAIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA PECTORIS; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UP-REGULATION;

EID: 84885201096     PISSN: 18975593     EISSN: 1898018X     Source Type: Journal    
DOI: 10.5603/CJ.2013.0071     Document Type: Article

References (20)

1. Venuraju SM, Yerramasu A, Corder R, Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol, 2010; 55: 2049-2061.
2. Yang Q, Lu S, Chen Y et al. Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions. Clin Cardiol, 2011; 34: 447-453.
3. Buemi M, Floccari F, Crisafulli A et al. Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofltration. J Nephrol, 2005; 18: 148-153.
4. Pedersen ER, Ueland T, Seifert R et al. Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. Atherosclerosis, 2010; 212: 644-649.
5. Jono S, Ikari Y, Shioi A et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation, 2002; 106: 1192-1194.
6. Celczynska-Bajew L, Horst-Sikorska W, Bychowiec B, Wykre-to wicz A, Wesoly J, Michalak M. The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. Kardiol Pol, 2011; 69: 573-578.
7. Kurnatowska I, Grzelak P, Kaczmarska M, Stefanczyk L, Nowicki M. Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcifcation in hemodialysis patients. Nephron Clin Pract, 2011; 117: c297-c304.
8. Mesquita M, Demulder A, Wolff F et al. Osteoprotegerin and progression of coronary and aortic calcifcations in chronic kidney disease. Transplant Proc, 2010; 42: 3444-3449.
9. Ren MY, Sui SJ, Zhang Y et al. Increased plasma osteoprotegerin levels are associated with the presence and severity of acute coronary syndrome. Acta Cardiol, 2008; 63: 615-622.
10. Sandberg WJ, Yndestad A, Oie E et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: Possible role in plaque destabilization. Arterioscler Thromb Vasc Biol, 2006; 26: 857-863.
11. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983; 51: 606.
12. Mogelvang R, Pedersen SH, Flyvbjerg A et al. Comparison of Osteoprotegerin to Traditional Atherosclerotic Risk Factors and High-Sensitivity C-Reactive Protein for Diagnosis of Atherosclerosis. Am J Cardiol, 2012; 109: 515-520.
13. Anand D V, Lahiri A, Lim E, Hopkins D, Corder R. The relationship between plasma osteoprotegerin levels and coronary artery calcifcation in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol, 2006; 47: 1850-1857.
14. Avignon A, Sultan A, Piot C, Elaerts Sp, Cristol J P, Dupuy AM. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care, 2005; 28: 2176-2180.
15. Schoppet M, Sattler AM, Schaefer JR, Herzum M, Maisch B, Hofbauer LC. Increased osteoprotegerin serum levels in men with coronary artery disease. J Clin Endocrinol Metab, 2003; 88: 1024-1028.
16. Reinhard H, Nybo M, Hansen PR et al. Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microal-buminuria. Cardiovasc Diabetol, 2011; 29:70.
17. Rhee EJ, Lee WY, Kim SY, Kim BJ, Sung KC ET AL. Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein. Clin Scien, 2005; 108: 237-243.
18. Jenkins PJ, Harper RW, Nestel PJ. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J, 1978; 2: 388-391.
19. Vik A, Mathiesen EB, Brox J et al. Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: The Tromso Study. J Thromb Haemost, 2011; 9: 638-644.
20. Omland T, Ueland T, Jansson AM et al. Circulating osteopro-tegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol, 2008; 51: 627-633.